Study shows hydroxychloroquine did not prevent coronavirus in health care workers | TheHill – The Hill

A new study has found that hydroxychloroquine, the anti-malaria drug that President TrumpDonald John TrumpTrump signs bill preventing shutdown after short funding lapse Privacy, civil liberties groups demand transparency from Amazon on election information breaches Facebook takes down Trump project advertisements connecting refugees to coronavirus MORE stated he took to ward off the coronavirus, did not prevent COVID-19 among health care workers.The study, released Wednesday in the journal JAMA Internal Medicine, was performed at two metropolitan medical facilities in between April 9 and July 13 amongst 132 full-time health care employees exposed to the infection. However, the trial was ended early.Some participants were provided 600 mg day-to-day doses of hydroxychloroquine, while others were given a placebo for 8 weeks.” There was no significant difference in infection rates in individuals randomized to receive hydroxychloroquine compared to placebo,” the researchers from the University of Pennsylvania wrote.Four of the 64 health care workers who were randomly given hydroxychloroquine wound up testing favorable for COVID-19 and four of the 61 healthcare workers who were provided a placebo tested positive.Among those 8 participants who checked positive, 6 developed viral signs. None required hospitalization and they all medically recuperated from the illness, according to the research study.” As such, we can not recommend the regular use of hydroxychloroquine among [health care employees] to prevent COVID-19,” researchers concluded.The findings of the recently released study appear similar to what was reported in a June research study in the New England Journal of Medicine, which discovered that hydroxychloroquine did not prevent health problem when used within 4 days of being exposed. In July, The Food and Drug Administration (FDA) withdrew the emergency usage authorization for both chloroquine and hydroxychloroquine due to major security issues.Doctors have cautioned that the drugs can cause serious heart problems, but the FDA had actually formerly enabled their usage for hospitalized clients and during clinical trials.Trump consistently promoted the drug as a prospective miracle treatment for the infection. He stated in May that he had actually been taking hydroxychloroquine, in mix with zinc, as a way to avoid getting COVID-19. Trumps promo of the drug has caused shortages for individuals that need it for other conditions. Hydroxychloroquine, which was at first approved as an anti-malaria drug, is also used to treat lupus and rheumatoid arthritis..

Leave a Reply

Your email address will not be published. Required fields are marked *